UGT1A7 is a UDP glucuronosyltransferase family member with complex functional properties. While some sources indicate it lacks traditional UGT glucuronidation activity and acts as a negative regulator, experimental evidence demonstrates that UGT1A7 does possess catalytic activity for various substrates including phenolic compounds, bulky phenols, and tertiary amines 1. The enzyme is predominantly expressed in human pancreatic tissue and several extrahepatic tissues 23. UGT1A7 shows significant susceptibility to inhibition by endogenous molecules such as glutaric acid (89.4% inhibition at 2mM) and linoleic acid, as well as environmental toxins like aflatoxins (>70% inhibition) 45. The clinical significance of UGT1A7 lies primarily in cancer susceptibility, where genetic polymorphisms, particularly the UGT1A7*3 allele, are associated with increased cancer risk in Asian populations 6. This allele confers low detoxification activity and shows strong associations with hepatocellular carcinoma, lung cancer, bladder cancer, and pancreatic diseases, especially in smokers and those with environmental toxin exposure 27. However, these associations may be population-specific, as no significant cancer risk was found in Italian patients 8.